These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8502817)

  • 1. Assessment of quality of life and benefits from adjuvant therapies in breast cancer.
    Aaronson NK
    Recent Results Cancer Res; 1993; 127():201-10. PubMed ID: 8502817
    [No Abstract]   [Full Text] [Related]  

  • 2. Life after adjuvant chemotherapy for breast cancer: the news is mostly good.
    Kiely BE; Wilcken NR; Stockler MR
    J Clin Oncol; 2011 Mar; 29(9):1092-3. PubMed ID: 21300925
    [No Abstract]   [Full Text] [Related]  

  • 3. Quality of life in clinical trials of adjuvant therapies. International Breast Cancer Study Group (formerly Ludwig Group).
    Gelber RD; Goldhirsch A; Hürny C; Bernhard J; Simes RJ
    J Natl Cancer Inst Monogr; 1992; (11):127-35. PubMed ID: 1385719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How does adjuvant chemotherapy affect menopausal symptoms, sexual function, and quality of life after breast cancer?
    Marino JL; Saunders CM; Emery LI; Green H; Doherty DA; Hickey M
    Menopause; 2016 Sep; 23(9):1000-8. PubMed ID: 27272225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality-of-life considerations in the adjuvant setting: critical review.
    Coates A
    Recent Results Cancer Res; 1993; 127():243-5. PubMed ID: 8502822
    [No Abstract]   [Full Text] [Related]  

  • 6. Health-related Quality of Life in Breast Cancer Patients after Adjuvant Treatments.
    Roine E; Blomqvist C; Kellokumpu-Lehtinen PL; Sintonen H; Saarto T
    Breast J; 2016 Jul; 22(4):473-5. PubMed ID: 27124555
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of dose-intensive chemotherapy on quality of life.
    Ahles TA
    Lancet Oncol; 2005 May; 6(5):258-9. PubMed ID: 15863373
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy.
    Joly F; Espié M; Marty M; Héron JF; Henry-Amar M
    Br J Cancer; 2000 Sep; 83(5):577-82. PubMed ID: 10944595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed?
    Simes RJ; Coates AS
    J Natl Cancer Inst Monogr; 2001; (30):146-52. PubMed ID: 11773309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy.
    Tubiana-Hulin M; Gardner M
    Cancer Treat Res; 2009; 151():121-37. PubMed ID: 19593510
    [No Abstract]   [Full Text] [Related]  

  • 11. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Side effects, quality-of-life issues, and trade-offs: the patient perspective.
    Langer AS
    J Natl Cancer Inst Monogr; 2001; (30):125-9. PubMed ID: 11773305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life assessment in the adjuvant setting: is it relevant? International Breast Cancer Study Group.
    Gelber RD; Bonetti M; Cole BF; Gelber S; Goldhirsch A
    Recent Results Cancer Res; 1998; 152():373-89. PubMed ID: 9928573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness and other assessments of adjuvant therapies for early breast cancer.
    Hillner BE; Smith TJ
    Oncology (Williston Park); 1995 Nov; 9(11 Suppl):129-34. PubMed ID: 8608043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial.
    Groenvold M; Fayers PM; Petersen MA; Mouridsen HT
    Breast Cancer Res Treat; 2006 Aug; 98(3):275-84. PubMed ID: 16541325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life and adjuvant tamoxifen treatment in breast cancer patients.
    Boehm DU; Lebrecht A; Eckhardt T; Albrich S; Schmidt M; Siggelkow W; Kandelhardt E; Koelbl H
    Eur J Cancer Care (Engl); 2009 Sep; 18(5):500-6. PubMed ID: 19490009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term effects of extended adjuvant endocrine therapy on quality of life in breast cancer patients.
    Kool M; Fontein DB; Meershoek-Klein Kranenbarg E; Nortier JW; Rutgers EJ; Marang-van de Mheen PJ; van de Velde CJ
    Breast; 2015 Jun; 24(3):224-9. PubMed ID: 25704982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring patient- and physician-related factors preventing breast cancer patients from guideline-adherent adjuvant chemotherapy-results from the prospective multi-center study BRENDA II.
    Schwentner L; Van Ewijk R; Kühn T; Flock F; Felberbaum R; Blettner M; Kreienberg R; Janni W; Wöckel A; Singer S
    Support Care Cancer; 2016 Jun; 24(6):2759-66. PubMed ID: 26816089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients.
    Berglund G; Bolund C; Fornander T; Rutqvist LE; Sjödén PO
    Eur J Cancer; 1991; 27(9):1075-81. PubMed ID: 1683557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of adjuvant chemotherapy on symptom burden and quality of life over time; a preliminary prospective observational study using individual data of patients aged ≥70 with early stage invasive breast cancer.
    Quinten C; Kenis C; Hamaker M; Coolbrandt A; Brouwers B; Dal Lago L; Neven P; Vuylsteke P; Debrock G; Van Den Bulck H; Smeets A; Schöffski P; Bottomley A; Wedding U; Wildiers H
    J Geriatr Oncol; 2018 Mar; 9(2):152-162. PubMed ID: 29167064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.